Request a copy of the file

Enter the following information to request a copy for the following item: L’empagliflozine (Jardiance ®), un nouvel hypoglycémiant dans le traitement du diabète de type 2, diminue aussi le risque cardiovasculaire : analyse d’une étude princeps

Requesting the following file: 2015_Buysschaert_LM_1348_403-408.pdf

This email address is used for sending the file.
Files
Back